CELU: Celularity Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 62.72
Enterprise Value ($M) 103.25
Book Value ($M) 27.81
Book Value / Share 1.26
Price / Book 2.26
NCAV ($M) -89.95
NCAV / Share -4.09
Price / NCAV -0.70

Profitability (mra)
Return on Invested Capital (ROIC) -1.19
Return on Assets (ROA) -0.72
Return on Equity (ROE) -3.73

Liquidity (mrq)
Quick Ratio 0.22
Current Ratio 0.26

Balance Sheet (mrq) ($M)
Current Assets 17.73
Assets 135.49
Liabilities 107.68
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-15 13D/A Dragasac Ltd 34.20 -89.64
02-08 13G/A UNITED THERAPEUTICS Corp 4.11 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-10-16 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-07-30 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-01-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 16,937 103,520 16.36
2024-11-21 28,237 91,594 30.83
2024-11-20 28,003 116,655 24.00
2024-11-19 49,152 250,737 19.60
2024-11-18 122,301 479,021 25.53

(click for more detail)

Similar Companies
CDMO – Avid Bioservices, Inc. CDTX – Cidara Therapeutics, Inc.
CDXC – ChromaDex Corporation CELZ – Creative Medical Technology Holdings, Inc.
CGEN – Compugen Ltd.


Financial data and stock pages provided by
Fintel.io